While these studies demonstrated relevance of TGFβ during liver disease progression, there is no conclusive evidence whether TGFβ alone could be a driver oncogene to initiate liver carcinogenesis or it only acts as a cofactor to promote/suppress tumor growth after carcinogenesis. Here, TGFB1 is linked to liver disorder.